Home
/ BTG
/ Competitors

BTG Competitors and Similar CompaniesClear all

BTG's competitors and similar companies include Affimed N.V., Avid Bioservices and Skyepharma.

	BTG BTG is an international specialist healthcare company.	Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.	Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.	Skyepharma Skyepharma is a drug delivery company developing oral and inhalation products.
Founding Date	Founding Date 1948	Founding Date 2000	Founding Date 1981	Founding Date 1996
Type	Type Subsidiary	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma	Tags Healthcare clinics pharma
Locations	Locations London, GB HQ Rosedale, AU Ottawa, CA Düsseldorf, DE Yokne'am Illit, IL see more	Locations Heidelberg, DE HQ	Locations Tustin, US HQ	Locations Saint-Quentin-Fallavier, FR HQ
Employees	Employees 640	Employees 76	Employees 21114% increase	Employees 2081% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 67.3 m	Valuation ($) 672.4 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) £731.3m (FY, 2019)	Revenue (est.) €8.3m (FY, 2023)	Revenue (est.) $139.9m (FY, 2024)	Revenue (est.) £95.9m (FY, 2015)
Cost of goods	Cost of goods £221m (FY, 2019)	Cost of goods N/A	Cost of goods $132.6m (FY, 2024)	Cost of goods £43.1m (FY, 2015)
Gross profit	Gross profit £510.3m (FY, 2019)	Gross profit €13m (FY, 2023)	Gross profit $7.3m (FY, 2024)	Gross profit £52.8m (FY, 2015)
Net income	Net income £88.3m (FY, 2019)	Net income (€105.9m) (FY, 2023)	Net income ($140.8m) (FY, 2024)	Net income N/A